New clues about how stars explode and forge the chemical elements that make up everything from planets to people have come to ...
Rapid and accurate disease detection is essential for early intervention, risk stratification, treatment guidance, and prognosis evaluation. Recent advances ...
Thermo Fisher rated Buy: accelerating organic growth, margin gains, and acquisitions boosting Pharma/Biotech exposure. Click ...
Branford-based Quantum-Si is cutting 20% of its workforce as it delays the launch of its Proteus protein analysis device.
Aug 13 (Reuters) - Lam Research (LRCX.O), opens new tab said on Thursday it intends to invest more than $3 billion in the next five years to expand its global research and development lab network, as ...
Like a delivery driver navigating crowded city streets, a gene-therapy-toting lipid nanoparticle faces a gauntlet of potential detours on its journey toward a cell's nucleus. First, there's entering ...
Eurofins CDMO Alphora has expanded its kilolab and high-potency active pharmaceutical ingredient (HPAPI) development and manufacturing capabilities in Mississauga.
Vivodyne's AI experiments on lab-grown human tissue could soon replace the need to test drugs on mice or dogs—and the approach has the potential to create drugs that work better.
Vivodyne says that eight of the world’s largest pharma companies have paid for early access to the human biological datacenter platform.
Emerging technologies like laboratory automation and generative AI are promising to revolutionize bioindustry workflows.
South Korea’s seven-part technology strategy sets targets for a 2030 robotic Moon landing, quantum computing, energy, biotech, and critical materials.
Bruker Corporation today announced an expanded strategic collaboration with Atinary Technologies Inc., the pioneer of Self-Driving Labs® technologies and AI-driven R&D with applications in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results